Discontinuation report CIPRALEX MELTZ
Report ID | 26436 |
Drug Identification Number | 02391457 |
Brand name | CIPRALEX MELTZ |
Common or Proper name | Escitalopram |
Company Name | LUNDBECK CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ESCITALOPRAM |
Strength(s) | 20MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | Blister pack of 30 tablets / Plaquette alvéolée de 30 comprimés |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2018-06-15 |
Actual discontinuation date | 2018-06-15 |
Remaining supply date | 2018-06-15 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2600 ALFRED-NOBEL, SUITE 400 ST-LAURENT, QUEBEC CANADA H4S 0A9 |
Company contact information | 514-844-8515 / Canada@Lundbeck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2018-07-24 | French | Compare |
v10 | 2018-07-24 | English | Compare |
v9 | 2018-05-31 | French | Compare |
v8 | 2018-05-31 | English | Compare |
v7 | 2017-11-01 | French | Compare |
v6 | 2017-11-01 | English | Compare |
v5 | 2017-10-30 | French | Compare |
v4 | 2017-10-30 | English | Compare |
v3 | 2017-10-20 | French | Compare |
v2 | 2017-10-20 | English | Compare |
v1 | 2017-10-20 | English | Compare |
Showing 1 to 11 of 11